TLX News: First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide - 2nd May 2023, 3:00am

[annb0t]

MELBOURNE, Australia, May 1, 2023 /CNW/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged in Canada with its commercially available prostate cancer imaging agent, Illuccix® [kit for the preparation of gallium (68Ga) PSMA-11 for intravenous injection]. (PRNewsfoto/Telix Pharmaceuticals Limited)

With Illuccix now available nationwide in Canada through Telix's partner Isologic Innovative Radiopharmaceuticals (Isologic), INITIO ...

>>> Read more: First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide